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Substitution of smokeless tobacco for cigarettes
in Buerger’s disease does not prevent limb loss
Peter F. Lawrence, MD, Olivia I. Lund, MA, Juan Carlos Jimenez, MD, and Rehan Muttalib,
Los Angeles, Calif
Buerger’s Disease, characterized by segmental, inflammatory, occlusive disease of the distal small and medium sized
arteries, predominantly affects young men who are cigarette smokers. The disease may lead to ischemia, necrosis, and
amputation of distal extremities; most patients have significant improvement in symptoms if smoking is discontinued. We
report a patient who experienced progression of biopsy-proven Buerger’s disease, after substituting smokeless tobacco for
cigarettes. The patient’s disease was severe enough to eventually require bilateral below-knee amputations. The
association of smokeless tobacco with progressive limb ischemia should lead clinicians to discourage the substitution of
smokeless tobacco for cigarette smoking in patients with Buerger’s disease. ( J Vasc Surg 2008;48:210-2.)Buerger’s disease is associated with significant morbid-
ity, ranging from ischemic rest pain to extremity amputa-
tion. Most patients smoke heavily and experience a dra-
matic improvement in symptoms and disease progression
following smoking cessation.1,2 This report identifies a
patient who experienced significant disease progression
after substituting smokeless tobacco for cigarettes. Smoke-
less tobacco has not been definitively reported to be asso-
ciated with Buerger’s disease, but should be avoided, based
on our experience with this patient.
CASE REPORT
A 21-year-old man with a 6-year history of superficial migra-
tory thrombophlebitis was referred for an ulcer of his left third toe
and an infected toenail on his great toe of the same foot. The
patient reported he had previously smoked one-half pack of ciga-
rettes daily per year and had recently been advised to discontinue
cigarettes, so he substituted smokeless tobacco, eventually con-
suming as much as one can daily over 5 years. He had no significant
exposure to secondhand smoke by history. At the time of referral,
he had no other atherosclerotic risk factors.
The patient complained of instep foot claudication, which had
progressed to ischemic rest pain bilaterally in both feet. The patient
denied any trauma to the skin of the involved digit or extremity.
Tests, including a complete blood count, erythrocyte sedimenta-
tion rate, platelets, prothrombin time/partial thromboplastin
time, factor V Leiden, anticardiolipin antibodies, homocysteine,
protein C, and protein S to screen for hypercoagulability, were
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210normal. Rheumatoid factor, antinuclear antibody, and lupus ery-
thematosus cell preparation were also normal. Skin biopsies re-
vealed chronic dermatitis, with moderate perivascular lymphocytic
infiltrates and erythema induratum. An erythematous area on the
third digit of his left foot became cyanotic, nodular, and eventually
ulcerated. The patient was started on cefotaxime and our vascular
surgery team was consulted for evaluation and treatment of the
ulcer.
On physical examination, upper and lower extremity periph-
eral pulses were normal to the elbow and knee, respectively. The
radial pulse was absent on the right side, and the dorsalis pedis and
posterior tibial pulses were absent bilaterally. Ankle-brachial in-
dexes were not obtainable and toe plethysmography waveforms
were flat. Both feet demonstrated ischemic changes, with depen-
dent rubor and atrophic, mottled skin. There was a 2-cm gangre-
nous ulcer on the third digit of the left foot with pus easily
expressible. The toenail on the great toe was infected and separated
from its bed. Pentoxifylline (Trental) and nifedipine (Procardia)
were instituted to improve peripheral blood flow but were ineffec-
tive.
Radiographs suggested osteopenia of the second through fifth
digits bilaterally with osteomyelitis of the distal left third toe.
Digital subtraction arteriography revealed normal aorta, iliac, and
femoral arteries. There was occlusion of the peroneal, posterior
tibial, and anterior tibial arteries bilaterally with collateralization of
the small vessels in the foot (Fig 1), typical for Buerger’s disease.
The distal vessels were inadequate for bypass. A venogram showed
an abnormal superficial venous system with an appearance indica-
tive of prior thrombosis with recanalization.
Angiography of the upper extremities (Fig 2) was performed
to evaluate the arterial anatomy after the patient presented later
with an ischemic finger. The angiogram of the right hand digits
(Fig 2, A) and wrist (Fig 2, B) demonstrated arterial disease typical
of Buerger’s disease. No disease was observed in the proximal
forearm arteries.
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tobacco permanently. Thrombolytic therapy and angioplasty re-
established flow through the left popliteal artery, but infrapopliteal
arteries could not be recanalized. The first and third digits did not
improve clinically and toe amputations were eventually performed.
The patient was discharged with satisfactory healing of the toe
amputations and treated for osteomyelitis with antibiotics.
The patient returned 6 months later (Table) with worsening
left foot digital ischemia and required below-knee amputation. It
was learned that the patient had continued to use excessive quan-
tities of smokeless tobacco (one can per day) despite our strongest
advice to abstain. Although the patient eventually quit chewing
tobacco, several revascularization procedures were attempted and
failed over the next 3 years. Intraoperative angiograms during
femoral-posterior tibial and femoral-peroneal bypasses demon-
strated poor outflow vessels and both grafts occluded within 30
days. He eventually required a below-knee amputation of the right
leg.
Segmental occlusive thrombi with lymphocytic infiltrates or
microabscesses were observed in the amputation specimens. These
Fig 1. Angiography of left lower extremity prior to below-knee
amputation. Left foot angiogram demonstrates typical Buerger’s
disease findings with occlusion of arteries and “corkscrew” collat-
erals.histological analyses repeatedly confirmed the clinical diagnosis ofBuerger’s disease. The patient now has bilateral below-knee am-
putations and walks with two prostheses. He has since discontin-
ued the use of smokeless tobacco and has had no further disease
progression in his upper extremities.
DISCUSSION
Buerger’s disease, or thromboangiitis obliterans, once
considered a variant of atherosclerosis, is now recognized as
a distinct clinical and pathologic entity.3,4 The characteris-
tic pathologic lesions have a pattern of segmental occlusive
Fig 2. Angiography of right upper extremity prior to first below-
knee amputation. A, Magnified views of the right hand demon-
strate digital artery occlusion. B, Angiogram of the right wrist
shows occlusion of the radial and ulnar arteries with normal
appearing arteries in the palmar arch. “Corkscrew” collaterals are
adjacent to the ulnar artery.thrombi with lymphocytic infiltrates or microabscesses of
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veins, which can be observed histologically.5 The most
common clinical presentation is a young male, like our
patient, who uses tobacco and complains of foot claudica-
tion, pain, or ulcers. Findings include migratory superficial
thrombophlebitis, diminished peripheral pulses and symp-
toms of ischemia, such as rubor, skin atrophy, skin ulcer-
ation, cyanosis, and paresthesias in distal extrimeties.1,2,6 It
is important to rule out other disorders, including hyper-
coagulable profiles, as there is no definitive laboratory test
for Buerger’s disease; however, histological study of a bi-
opsy sample is helpful in diagnosis.
The observation that continued cigarette smoking ex-
acerbates Buerger’s disease while cessation of smoking usu-
ally results in dramatic improvement is well established.
What has not been emphasized is the relationship between
smokeless tobacco and Buerger’s disease. Under the pretext
of a harm-reduction method, some physicians have advised
patients to replace cigarette smoking with smokeless tobacco,
if they are unable to discontinue smoking7,8; this is the reason
why our patient had switched to smokeless tobacco. We
report this case to inform clinicians that the same association
exists between smokeless tobacco and Buerger’s disease as
exists between cigarette smoking and Buerger’s disease, so
that further morbidity can be prevented in these patients.
While one report hypothesizes that the frequency of
Buerger’s disease will increase with the increase of athletes’
use of smokeless tobacco,9 we are aware of only two other
suggestions of a potential relationship between thrombo-
angiitis obliterans and smokeless tobacco.10,11 In these
reports, the patients used smaller quantities of smokeless
tobacco (one and one-half cans per week) and were not
well documented Buerger’s patients. In contrast, our
patient used a large quantity of smokeless tobacco (five
to seven cans per week), and we have tissue obtained
following several amputations to confirm and reconfirm
Table. Timeline of clinical events
Months
Consultation by our vascular team 0
Thrombolytic therapy and left popliteal angioplasty 1
First and third toes amputated from left foot 2
Left leg below-knee amputation 8
Right leg femoral-posterior tibial bypass – failed 10
Right leg femoral-peroneal bypass – failed 11
Right leg below-knee amputation 13the diagnosis.Although Buerger’s disease may rarely occur in the ab-
sence of tobacco use, the overwhelming majority of patients
smoke and experience dramatic improvement following ces-
sation.12,13 Our patient abstained from cigarettes following
his Buerger’s disease diagnosis and switched to smokeless
tobacco, believing it to be an acceptable substitute. Despite
aggressive medical treatment and repeated counseling, he
continued to use smokeless tobacco and his disease pro-
gressed. Only after his initial below-knee amputation did the
patient quit; however, the disease at that time was so extensive
that his contralateral leg could not be salvaged.
Our report provides strong evidence for the association
between smokeless tobacco use and development of Buerger’s
disease and supports other literature relating tobacco use to
vascular disease. Complete abstinence from the use of all
tobacco, including cigarettes, cigars, and smokeless tobacco, is
advisable in these patients.
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